News

The number of teenagers with diabetes is on the rise, and obesity is a major contributing factor. According to the American Diabetes Association, one in four teenagers in the United States is obese, and those who are obese are more likely to develop type 2 diabetes. Type 2 diabetes is …

In 2021, the FDA approved the Bigfoot Unity Diabetes Management System, which includes smart pen caps that recommend insulin doses. This is the first FDA-approved device that uses artificial intelligence (AI) to help people with diabetes manage their condition. The smart pen caps work by connecting to a continuous glucose …

The Dexcom G6 is a continuous glucose monitoring (CGM) system that has been shown to be very accurate. In a recent study, the G6 was compared to fingerstick glucose measurements in people with type 1 diabetes. The study found that the G6 was accurate within 9% of fingerstick measurements for …

Gone with the Glucose: Embrace the Laser that Monitors Blood Sugar For people with diabetes, monitoring blood sugar levels is essential for managing the condition. Traditional glucose meters require a finger prick to obtain a blood sample, which can be painful and inconvenient. However, there is a new technology on …

The American Diabetes Association (ADA) has released its updated Standards of Care in Diabetes for 2023. The guidelines include a number of new recommendations, including: A focus on supporting higher weight loss (up to 15%). The ADA now recommends that people with diabetes aim to lose 5-10% of their body …

The ADA regularly updates its Standards of Medical Care in Diabetes to reflect the most current evidence-based recommendations for diabetes management. These updates incorporate the latest research findings, clinical trial data, and expert consensus to provide healthcare professionals with guidelines for treating individuals with diabetes effectively. To find the most …

Emerging research suggests that some diabetes medications may have potential benefits in reducing the risk of developing Alzheimer’s disease or slowing its progression. Alzheimer’s disease is a neurodegenerative condition characterized by memory loss and cognitive decline. While the exact cause of Alzheimer’s is not fully understood, there is growing evidence …

Yes, some antacid medications, specifically proton pump inhibitors (PPIs), have been found to have potential effects on blood sugar management, especially in individuals with type 2 diabetes. PPIs are commonly used to treat conditions such as gastroesophageal reflux disease (GERD), peptic ulcers, and other acid-related gastrointestinal disorders. While PPIs are …

Time-restricted eating (TRE), also known as intermittent fasting, is a dietary approach that limits the eating window to a specific period during the day and involves fasting for the remaining hours. Emerging research suggests that TRE may have beneficial effects on various health parameters, including blood pressure, and could potentially …

From baseline to 15 months, increases in overweight prevalence were significantly greater in control versus intervention schools